Ecallantide for the Acute Treatment of Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema: A Multicenter, Randomized, Controlled Trial
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 65 (2) , 204-213
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Angiotensin-converting enzyme inhibitor–induced angioedema in a community hospital emergency departmentAnnals of Allergy, Asthma & Immunology, 2009
- Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency departmentAnnals of Allergy, Asthma & Immunology, 2008
- Ten-year study of causes of moderate to severe angioedema seen by an inpatient allergy/immunology consult serviceAllergy and Asthma Proceedings, 2008
- Angiotensin-Converting Enzyme Inhibitor-Associated AngioedemaImmunology and Allergy Clinics of North America, 2006
- Incidence and Characteristics of Angioedema Associated With EnalaprilArchives of internal medicine (1960), 2005
- An evaluation of risk factors for adverse drug events associated with angiotensin‐converting enzyme inhibitorsJournal of Evaluation in Clinical Practice, 2004
- Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trialAmerican Journal of Hypertension, 2004
- Bradykinin and the pathophysiology of angioedemaInternational Immunopharmacology, 2003
- Pathways for bradykinin formation and inflammatory diseaseJournal of Allergy and Clinical Immunology, 2002
- ACE Inhibitor???Induced AngioedemaDrug Safety, 1998